Evolution and Validation 0f Practice Standards, Training, and Professional Development
Jacobi J, Fraser GL, Coursin DB, et al. Clinical
practice guidelines for the sustained use of sedatives
and analgesics in the critically ill adult [published
Crit
Care
Med.
2002;30(1):119-141.
https://doi.
org/10.1097/00003246-200201000-00020
Joint
Commission
of
Pharmacy
Practitioners.
Pharmacistsβ patient care process. May 2014. http://jcpp.
net/patient-care-process/
Kane SL, Weber RJ, Dasta JF. The impact of critical care
pharmacists on enhancing patient outcomes. Intensive
s00134-003-1705-3
Kim MM, Barnato AE, Angus DC, Fleisher LA, Kahn JM.
The effect of multidisciplinary care teams on intensive
care unit mortality. Arch Intern Med. 2010;170(4):369-
376. https://doi.org/10.1001/archinternmed.2009.521
Lat I, Paciullo C, Daley MJ, et al. Position paper on
critical care pharmacy services (executive summary):
https://doi.org/10.1097/ccm.0000000000004438
Leape LL, Cullen DJ, Clapp MD, et al. Pharmacist
participation on physician rounds and adverse drug
270. https://doi.org/10.1001/jama.282.3.267
Lee H, Ryu K, Sohn Y, Kim J, Suh GY, Kim E. Impact
on patient outcomes of pharmacist participation in
multidisciplinary critical care teams: a systematic review
1250. https://doi.org/10.1097/ccm.0000000000003830
Leguelinel-Blache G, Nguyen TL, Louart B, et al.
Impact of quality bundle enforcement by a critical
care pharmacist on patient outcome and costs. Crit
ccm.0000000000002827
Louzon P, Jennings H, Ali M, Kraisinger M. Impact
of pharmacist management of pain, agitation, and
delirium in the intensive care unit through participation
Pharm.
2017;74(4):253-262.
https://doi.org/10.2146/
ajhp150942
MacLaren R, Bond CA. Effects of pharmacist
participation in intensive care units on clinical
and economic outcomes of critically ill patients
with thromboembolic or infarction-related events.
2009;29(7):761-768.
https://doi.
org/10.1592/phco.29.7.761
MacLaren R, Bond CA, Martin SJ, Fike D. Clinical
and economic outcomes of involving pharmacists in
the direct care of critically ill patients with infections.
org/10.1097/ccm.0b013e31818f2269
MacLaren R, Devlin JW, Martin SJ, Dasta JF, Rudis
MI, Bond CA. Critical care pharmacy services in United
618. https://doi.org/10.1345/aph.1g590
MacLaren R, Plamondon JM, Ramsay KB, Rocker
GM, Patrick WD, Hall RI. A prospective evaluation of
empiric versus protocol-based sedation and analgesia.
2000;20(6):662-672.
https://doi.
org/10.1592/phco.20.7.662.35172
MacLaren R, Roberts RJ, Dzierba AL, Buckley
M, Lat I, Lam SW. Characterizing critical care
pharmacy services across the United States. Crit
Care Explor. 2021;3(1):e0323. https://doi.org/10.1097/
cce.0000000000000323
Marshall J, Finn CA, Theodore AC. Impact of a clinical
pharmacist-enforced intensive care unit sedation
protocol on duration of mechanical ventilation and
doi.org/10.1097/01.ccm.0000300275.63811.b3
Mitchell P, Wynia M, Golden R, et al. Core principles &
values of effective team-based health care. Discussion
paper. Institute of Medicine; 2012. https://nam.edu/
wp-content/uploads/2015/06/VSRT-Team-Based-Care-
Principles-Values.pdf
Moheet AM, Livesay SL, Abdelhak T, et al. Standards
for neurologic critical care units: a statement for
healthcare professionals from The Neurocritical Care
Society. Neurocrit Care. 2018;29(2):145-160. https://doi.
org/10.1007/s12028-018-0601-1
Montazeri M, Cook DJ. Impact of a clinical
pharmacist in a multidisciplinary intensive care unit.
org/10.1097/00003246-199406000-00027
Murray MJ, DeBlock H, Erstad B, et al. Clinical
practice
guidelines
for
sustained
neuromuscular
Med. 2016;44(11):2079-2103. https://doi.org/10.1097/
ccm.0000000000002027